SHIELD Illinois Revenue and Competitors

Urbana, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • SHIELD Illinois's estimated annual revenue is currently $30.1M per year.(i)
  • SHIELD Illinois's estimated revenue per employee is $201,000

Employee Data

  • SHIELD Illinois has 150 Employees.(i)
  • SHIELD Illinois grew their employee count by -22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M6530%N/AN/A
#2
$75.6M3767%N/AN/A
#3
$23.9M11913%$35MN/A
#4
$12.7M63-3%N/AN/A
#5
$5.4M27-25%N/AN/A
#6
$6M30-35%N/AN/A
#7
$6.6M33-8%N/AN/A
#8
$13.5M67-3%N/AN/A
#9
$186.3M92719%N/AN/A
#10
$4.4M22-4%N/AN/A
Add Company

What Is SHIELD Illinois?

SHIELD Illinois is a COVID-19 screening testing program and infrastructure that deploys the University of Illinois' innovative saliva test across the state. We are launching labs across Illinois to increase capacity and access. Patients typically receive results within 24 hours and our test has a specificity of 99.8-99.9% with very few false positives.

keywords:N/A

N/A

Total Funding

150

Number of Employees

$30.1M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SHIELD Illinois News

2022-03-22 - With Sharp Drop in Demand, Community-Based COVID-19 ...

SPRINGFIELD – The Illinois Department of Public Health (IDPH) announced today ... number of SHIELD saliva testing sites throughout Illinois,...

2022-03-22 - Community-based COVID 19 testing sites in Illinois will close at the end of March

ILLINOIS (WSIL) -- Illinois is ending the operation of ... tests and a network of SHIELD saliva tests sites also factor in to the decision.

2022-03-22 - Illinois to shut down all community-based COVID-19 testing ...

The Illinois Department of Public Health (IDPH) announced on Friday ... kits and visiting SHIELD saliva testing sites throughout the state.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M168N/AN/A
#2
$15M19414%N/A
#3
$53.6M1985%N/A
#4
$15M213N/AN/A
#5
$35M2308%N/A